Whitehawk Therapeutics, Inc. SEC filings WHWK

Whitehawk Therapeutics, Inc. has 671 filings in SEC EDGAR's recent list, going back to Feb 1, 2008. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 10, 2026 (officer or director change). The company's fiscal year ends on December 31.

Whitehawk Therapeutics, Inc. SEC filings
Form Description Filed Period
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
10-K Annual report Mar 12, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
10-K Annual report Mar 28, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
10-K Annual report Mar 13, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
10-K Annual report Mar 29, 2023 Dec 31, 2022
10-K Annual report Mar 17, 2022 Dec 31, 2021
10-K Annual report Mar 11, 2021 Dec 31, 2020
10-K Annual report Mar 16, 2020 Dec 31, 2019
10-K Annual report Mar 7, 2019 Dec 31, 2018
10-K/A Amended annual report Apr 6, 2018 Dec 31, 2017
10-K Annual report Mar 15, 2018 Dec 31, 2017
10-K Annual report Mar 7, 2017 Dec 31, 2016
10-K Annual report Mar 30, 2016 Dec 31, 2015
10-K Annual report Feb 27, 2015 Dec 31, 2014
10-K Annual report Mar 31, 2014 Dec 31, 2013
10-K Annual report Mar 28, 2013 Dec 31, 2012
10-K Annual report Mar 30, 2012 Dec 31, 2011
10-K Annual report Mar 31, 2011 Dec 31, 2010
10-K Annual report Mar 31, 2010 Dec 31, 2009
10-K Annual report Mar 31, 2009 Dec 31, 2008

Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
WHWK (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Morristown, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1422142
Former names
Aadi Bioscience, Inc. (until Mar 18, 2025); Aerpio Pharmaceuticals, Inc. (until Aug 23, 2021); ZETA ACQUISITION CORP II (until Mar 13, 2017)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.